Effect Of Neutralizing IL-17A and IL-17F Antibodies On Host Resistance To Acute Mycobacterium Tuberculosis Infection In Mice In Comparison With Neutralizing TNF-α Treatment

被引：0
|
作者：
Kammueller, Michael [1 ]
Di Padova, Franco [1 ]
Antoni, Christian [2 ]
Chibout, Salah-Dine [1 ]
Wright, Timothy [3 ]
Bourigault, Marie-Laure [4 ,5 ]
Segueni, Noria [4 ,5 ]
Rose, Stephanie [4 ,5 ]
Ryffel, Bernhard [4 ,5 ]
Quesniaux, Valerie [4 ,5 ]
机构：
[1] Novartis Inst Biomed Res, Basel, Switzerland
[2] Novartis Pharmaceut, E Hanover, NJ USA
[3] Novartis Pharma AG, Basel, Switzerland
[4] CNRS, UMR7355, F-45071 Orleans, France
[5] Univ Orleans, Orleans, France
来源：
ARTHRITIS AND RHEUMATISM | 2013年 / 65卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
931
引用
收藏
页码：S399 / S399
页数：1
相关论文
共 50 条
  • [1] The importance of IL-17A and IL-17F during Mycobacterium tuberculosis infection
    Behrends, J.
    Rueckerl, D.
    Keller, C.
    Volz, J.
    Hoelscher, A.
    Iwakura, Y.
    Ehlers, S.
    Hoelscher, C.
    INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY, 2011, 301 : 46 - 47
  • [2] Controlled Mycobacterium tuberculosis infection in mice under treatment with anti-IL-17A or IL-17F antibodies, in contrast to TNFα neutralization
    Noria Segueni
    Elaine Tritto
    Marie-Laure Bourigault
    Stéphanie Rose
    François Erard
    Marc Le Bert
    Muazzam Jacobs
    Franco Di Padova
    Daniel P. Stiehl
    Pierre Moulin
    Dominique Brees
    Salah-Dine Chibout
    Bernhard Ryffel
    Michael Kammüller
    Valerie F. Quesniaux
    Scientific Reports, 6
  • [3] Controlled Mycobacterium tuberculosis infection in mice under treatment with anti-IL-17A or IL-17F antibodies, in contrast to TNFα neutralization
    Segueni, Noria
    Tritto, Elaine
    Bourigault, Marie-Laure
    Rose, Stephanie
    Erard, Francois
    Le Bert, Marc
    Jacobs, Muazzam
    Di Padova, Franco
    Stiehl, Daniel P.
    Moulin, Pierre
    Brees, Dominique
    Chibout, Salah-Dine
    Ryffel, Bernhard
    Kammuller, Michael
    Quesniaux, Valerie F.
    SCIENTIFIC REPORTS, 2016, 6
  • [4] The involvement of IL-17A and IL-17F in chronic pulmonary mycobacterial infection
    Umemura, M.
    Fukui, M.
    Tamura, T.
    Nakae, S.
    Iwakura, Y.
    Matsuzaki, G.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2016, 46 : 1250 - 1250
  • [5] COMPARISON OF IL-17A AND IL-17F EFFECTS ON DIFFERENT CELL TYPES
    Noack, M.
    Miossec, P.
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : A43 - A43
  • [6] IL-17A Controls IL-17F Production and Maintains Blood Neutrophil Counts in Mice
    von Vietinghoff, Sibylle
    Ley, Klaus
    JOURNAL OF IMMUNOLOGY, 2009, 183 (02): : 865 - 873
  • [7] Bimekizumab: a dual IL-17A and IL-17F inhibitor for the treatment of psoriasis and psoriatic arthritis
    Ali, Zara
    Matthews, Raymond
    Al-Janabi, Ali
    Warren, Richard B.
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2021, 17 (10) : 1073 - 1081
  • [8] Investigating the contribution of IL-17A and IL-17F to the host response during Escherichia coli mastitis
    Roussel, Perrine
    Cunha, Patricia
    Porcherie, Adeline
    Petzl, Wolfram
    Gilbert, Florence B.
    Riollet, Celine
    Zerbe, Holm
    Rainard, Pascal
    Germon, Pierre
    VETERINARY RESEARCH, 2015, 46
  • [9] Investigating the contribution of IL-17A and IL-17F to the host response during Escherichia coli mastitis
    Perrine Roussel
    Patricia Cunha
    Adeline Porcherie
    Wolfram Petzl
    Florence B Gilbert
    Céline Riollet
    Holm Zerbe
    Pascal Rainard
    Pierre Germon
    Veterinary Research, 46
  • [10] Small molecule inhibitors of IL-17A and IL-17F secretion for the treatment of autoimmune diseases
    Tasler, Stefan
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2012, 244
12345